Viewing Study NCT00509093


Ignite Creation Date: 2025-12-25 @ 1:21 AM
Ignite Modification Date: 2026-02-28 @ 9:25 PM
Study NCT ID: NCT00509093
Status: COMPLETED
Last Update Posted: 2020-03-17
First Post: 2007-07-30
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy
Sponsor: Case Comprehensive Cancer Center
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-10
Start Date Type: None
Primary Completion Date: 2014-05-09
Primary Completion Date Type: ACTUAL
Completion Date: 2015-04-09
Completion Date Type: ACTUAL
First Submit Date: 2007-07-30
First Submit QC Date: None
Study First Post Date: 2007-07-31
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2020-02-20
Results First Submit QC Date: None
Results First Post Date: 2020-03-04
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-03-04
Last Update Post Date: 2020-03-17
Last Update Post Date Type: ACTUAL